Innodem Neurosciences Biotech

Market - Biotech

Location - Montreal, Canada

Description - Innodem works with the pharmaceutical industry, leading medical professionals, and artificial intelligence experts to develop and promote Eye Movement Biomarkers (EMBs) & Gaze Mapping Biomarkers (GMBs) as important clinical assessment tools in the field of neurology. It is building a series of disease-specific tests embodied in an intuitive App that captures EMB & GMB data. The vision is that over time, while leveraging the latest advances in machine and deep learning, this EMB/GMB platform will assist users to accurately diagnose and monitor neurological disorders affecting eye-movements or cognition such as multiple sclerosis, Alzheirmer’s, Parkinson’s or related disorders, Frontotemporal dementia, Cancer-related cognitive impairment (Chemo Brain) and many others.

Tags - Alzheimer Parkinson Cancer-Related Cognitive Impairment Frontotemporal Dementia Eye Movement Biomarkers Gaze Mapping Biomarkers Innodem HIPAA PIPEDA